Hisamitsu Pharmaceutical Co (FSE:4530) Other Current Liabilities: 円38,469 Mil (As of Nov. 2025)


FSE:4530 Hisamitsu Pharmaceutical Co Inc FSE:4530
89 GF Score
Price 円3,975.00
GF Value 円3,237.07
View Full Analysis

What is Hisamitsu Pharmaceutical Co Other Current Liabilities?

Hisamitsu Pharmaceutical Co FSE:4530 89 Other Current Liabilities is 円38,469 Mil as of Nov. 2025. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07.

Hisamitsu Pharmaceutical Co's other current liabilities for the quarter that ended in Nov. 2025 was 円38,469 Mil.

Hisamitsu Pharmaceutical Co's quarterly other current liabilities increased from May. 2025 (円34,215 Mil) to Aug. 2025 (円36,504 Mil) and increased from Aug. 2025 (円36,504 Mil) to Nov. 2025 (円38,469 Mil).

Hisamitsu Pharmaceutical Co's annual other current liabilities declined from Feb. 2024 (円25,044 Mil) to Feb. 2025 (円24,063 Mil) but then increased from Feb. 2025 (円24,063 Mil) to Feb. 2026 (円26,075 Mil).

Hisamitsu Pharmaceutical Co Other Current Liabilities Related Terms

Hisamitsu Pharmaceutical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Other Current Liabilities Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,632.00 24,242.00 25,044.00 24,063.00 26,075.00

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,063.00 34,215.00 36,504.00 38,469.00 26,075.00
FSE:4530
89GF Score
Hisamitsu Pharmaceutical Co Inc FSE:4530
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円38,469 Mil mean?
Hisamitsu Pharmaceutical Co (FSE:4530) has a Other Current Liabilities of 円38,469 Mil as of Nov. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Hisamitsu Pharmaceutical Co.
Is Hisamitsu Pharmaceutical Co's Other Current Liabilities too high?
Hisamitsu Pharmaceutical Co's current Other Current Liabilities is 円38,469 Mil. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Other Current Liabilities compare to ESPR and AMPH?
Hisamitsu Pharmaceutical Co's Other Current Liabilities of 円38,469 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Hisamitsu Pharmaceutical Co. Hisamitsu Pharmaceutical Co's current Other Current Liabilities is 円38,469 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current Other Current Liabilities of 円38,469 Mil. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current Other Current Liabilities is 円38,469 Mil. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current Other Current Liabilities is 円38,469 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.

Key valuation signals for FSE:4530:

  • Other Current Liabilities: 円38,469 Mil
  • GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
  • GF Score™: 89/100

No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score

Get the complete analysis for FSE:4530

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,975.00
Price
円3,237.07
GF Value